Back

ONWARD sells 159 ARC-EX systems, up 430% in first-half 2026

Verifying
  • ONWARD Medical reported first-half commercial, clinical and financial progress across its neurotechnology pipeline.
  • 159 ARC-EX Systems were sold or supplied through paid evaluations, a 430% year-over-year increase.
  • The company enrolled 22 Empower BP participants across 14 actively recruiting clinical sites.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.